Next-Gen Avisi Technologies Aims for “One and Done” in a MIGS Device

Some medtech start-ups begin with an inventor with a novel idea; others seek out an unmet clinical need looking for a solution. Avisi Technologies began with market research, that is, a direct appeal to glaucoma specialists to determine what they were missing in their tool kits, and specifically, how the current generation of devices for minimally invasive glaucoma surgery (MIGS) might be falling short.

Share this article: